Voltar
Artigo Acesso aberto Revisado por pares
BIBTEX RIS

Phase III Clinical Trials That Integrate Treatment and Biomarker Evaluation

2013; Lippincott Williams & Wilkins; Volume: 31; Issue: 25 Linguagem: Inglês

10.1200/jco.2012.48.3826

ISSN

1527-7755

Autores

Boris Freidlin, Zhuoxin Sun, Robert J. Gray, Edward L. Korn,

Tópico(s)

Cancer Genomics and Diagnostics

Resumo

Article Tools STATISTICS IN ONCOLOGY Article Tools OPTIONS & TOOLS Export Citation Track Citation Add To Favorites Rights & Permissions COMPANION ARTICLES No companion articles ARTICLE CITATION DOI: 10.1200/JCO.2012.48.3826 Journal of Clinical Oncology - published online before print April 8, 2013 PMID: 23569306 Phase III Clinical Trials That Integrate Treatment and Biomarker Evaluation Boris FreidlinxBoris FreidlinSearch for articles by this author , Zhuoxin SunxZhuoxin SunSearch for articles by this author , Robert GrayxRobert GraySearch for articles by this author , Edward L. KornxEdward L. KornSearch for articles by this author Show More Boris Freidlin and Edward L. Korn, National Cancer Institute, Bethesda, MD; and Zhuoxin Sun and Robert Gray, Eastern Cooperative Oncology Group, and Dana-Farber Cancer Institute, Boston, MA. https://doi.org/10.1200/JCO.2012.48.3826 First Page Full Text PDF Figures and Tables © 2013 by American Society of Clinical Oncology

Referência(s)